Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma

Posterior reversible encephalopathy syndrome (PRES) is a rare but severe neurological syndrome that may stem from the use of some medications. Although its mechanism is not well-known, hypertension and endothelial dysfunction have been mentioned in previous literature as being related. Lenvatinib se...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yu-Ju Tseng, Chun-Nan Chen, Ruey-Long Hong, Woon-Man Kung, Abel Po-Hao Huang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2022-12-01
Sarja:	Brain Sciences
Aiheet:	posterior reversible encephalopathy syndrome lenvatinib olfactory neuroblastoma
Linkit:	https://www.mdpi.com/2076-3425/13/1/33
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!